Fahad Ibrahim Al-Saikhan
Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 11942 Al-Kharj, Saudi Arabia
LiveDNA: 966.20248
Mohamed Abd-Elghany Abd-Elaziz
Department of Clinical Pharmacology, Mansoura Faculty of Medicine, Mansoura University, 35516 Mansoura, Egypt
Rehab Hamdy Ashour
Department of Clinical Pharmacology, Mansoura Faculty of Medicine, Mansoura University, 35516 Mansoura, Egypt
Taimour Langaee
Department of Pharmacotherapy and Translational Research at the University of Florida (UF), College of Pharmacy, Gainesville, 32610 FL, Florida
PDF Fulltext XML References Citation
How to cite this article
Fahad Ibrahim Al-Saikhan, Mohamed Abd-Elghany Abd-Elaziz, Rehab Hamdy Ashour and Taimour Langaee, 2018. Impact of Cytochrome P450 2C9 Polymorphism on Warfarin Therapy in Saudi Population. International Journal of Pharmacology, 14: 566-571.
DOI: 10.3923/ijp.2018.566.571
URL: https://scialert.net/abstract/?doi=ijp.2018.566.571
DOI: 10.3923/ijp.2018.566.571
URL: https://scialert.net/abstract/?doi=ijp.2018.566.571